Actuate Therapeutics Inc
ACTU · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $143 | $120 | $132 | $86 |
| - Cash | $17 | $6 | $4 | $9 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $126 | $114 | $128 | $78 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$5 | -$6 | -$6 | -$6 |
| % Margin | – | – | – | – |
| Net Income | -$5 | -$6 | -$6 | -$6 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.25 | -0.3 | -0.32 | -0.6 |
| % Growth | 16.7% | 6.3% | 46.7% | – |
| Operating Cash Flow | -$7 | -$4 | -$5 | -$5 |
| Capital Expenditures | $0 | -$0 | $0 | $0 |
| Free Cash Flow | -$7 | -$4 | -$5 | -$5 |